Sergio E Chiarella Selected Research

Vaccine Excipients

2/2022	Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions.
1/2022	Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sergio E Chiarella Research Topics

Disease

6	Asthma (Bronchial Asthma) 02/2022 - 01/2015
4	Thrombosis (Thrombus) 02/2019 - 04/2011
4	Pneumonia (Pneumonitis) 01/2012 - 07/2009
4	Lung Injury 01/2012 - 04/2011
3	COVID-19 02/2022 - 01/2022
3	Hypersensitivity (Allergy) 02/2022 - 01/2020
2	Fibrosis (Cirrhosis) 02/2012 - 06/2011
2	Acute Lung Injury 01/2012 - 04/2011
2	Hyperoxia 01/2012 - 04/2011
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2011 - 04/2011
1	Neoplasms (Cancer) 01/2022
1	Eczema 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Urticaria (Hives) 01/2022
1	Rhinitis 01/2022
1	Anaphylaxis (Anaphylactic Shock) 10/2021
1	Vasculitis (Vasculitides) 10/2021
1	Atopic Dermatitis (Atopic Eczema) 01/2021
1	Obesity 01/2021
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Cutaneous Lupus Erythematosus 01/2020
1	Schnitzler Syndrome 01/2018
1	Idiopathic Pulmonary Fibrosis 02/2012
1	Human Influenza (Influenza) 01/2012
1	Infections 01/2012
1	Alcoholism (Alcohol Abuse) 01/2012
1	Weight Loss (Weight Reduction) 01/2012
1	Sepsis (Septicemia) 01/2012
1	Lung Neoplasms (Lung Cancer) 01/2012
1	Body Weight (Weight, Body) 09/2011
1	Inflammation (Inflammations) 06/2011

Drug/Important Bio-Agent (IBA)

4	Particulate MatterIBA 01/2019 - 07/2009
3	VaccinesIBA 02/2022 - 01/2022
3	Messenger RNA (mRNA)IBA 02/2022 - 10/2021
3	COVID-19 VaccinesIBA 02/2022 - 10/2021
3	CytokinesIBA 12/2021 - 01/2012
2	Histamine Antagonists (Antihistamines)IBA 02/2022 - 01/2022
2	Vaccine ExcipientsIBA 02/2022 - 01/2022
2	Insulin (Novolin)FDA Link 01/2022 - 01/2021
2	Metformin (Glucophage)FDA LinkGeneric 02/2019 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 07/2014
2	Bleomycin (Blenoxane)FDA LinkGeneric 02/2012 - 06/2011
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 04/2011
2	Oxidants (Oxidizing Agents)IBA 06/2011 - 04/2011
1	Excipients (Suspending Agents)IBA 02/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 02/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2022
1	Hormones (Hormone)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	SARS-CoV-2 spike proteinIBA 01/2022
1	SteroidsIBA 01/2022
1	benralizumabIBA 12/2021
1	Polysorbates (PSML)FDA Link 10/2021
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2021
1	CeramidesIBA 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Progesterone FDA LinkGeneric 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Testosterone (Sustanon)FDA Link 01/2021
1	Proton Pump InhibitorsIBA 01/2020
1	AllergensIBA 01/2020
1	Calcium Release Activated Calcium ChannelsIBA 01/2019
1	Interleukin-17 (Interleukin 17)IBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 07/2014
1	Proteasome InhibitorsIBA 02/2012
1	Bortezomib (Velcade)FDA Link 02/2012
1	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2012
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2012
1	SodiumIBA 01/2012
1	Adenosine Triphosphatases (ATPase)IBA 01/2012
1	Adenosine (Adenocard)FDA LinkGeneric 01/2012
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2012
1	Adenosine A1 ReceptorIBA 01/2012
1	Laminin (Merosin)IBA 09/2011
1	Tight Junction ProteinsIBA 06/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 06/2011
1	LeptinIBA 06/2011
1	Mitochondrial Permeability Transition PoreIBA 04/2011
1	Cyclophilins (Cyclophilin)IBA 04/2011
1	Etanercept (Enbrel)FDA Link 04/2011
1	Plasminogen Activator Inhibitor 1IBA 04/2011

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2012